Repeated hepatocyte growth factor neutralizing antibody treatment leads to HGF/SF unresponsiveness in human glioblastoma multiforme cells
- 28 May 2010
- journal article
- Published by Elsevier in Cancer Letters
- Vol. 291 (2) , 209-216
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Cancer and venous thromboembolismThe Lancet Oncology, 2005
- Met, metastasis, motility and moreNature Reviews Molecular Cell Biology, 2003
- Scatter-factor and semaphorin receptors: cell signalling for invasive growthNature Reviews Cancer, 2002
- Neutralizing monoclonal antibodies to hepatocyte growth factor/scatter factor (HGF/SF) display antitumor activity in animal modelsProceedings of the National Academy of Sciences, 2001
- Levels of vascular endothelial growth factor, hepatocyte growth factor/scatter factor and basic fibroblast growth factor in human gliomas and their relation to angiogenesisInternational Journal of Cancer, 1999
- Hepatocyte Growth Factor Is a Major Mediator in Heparin-Induced AngiogenesisBiochemical and Biophysical Research Communications, 1999
- The Met Proto-Oncogene Mesenchymal to Epithelial Cell ConversionScience, 1994
- The met Proto-Oncogene Receptor and Lumen FormationScience, 1992
- Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factorCell, 1991
- Identification of the Hepatocyte Growth Factor Receptor As the c- met Proto-Oncogene ProductScience, 1991